The McGill University Health Centre is one of two major healthcare networks in the city of Montreal, Quebec. It is affiliated with McGill University and is one of the largest medical institutions in Canada. It is the largest hospital system in Canada by bed capacity.

There are 1,379 beds in Montreal Gen Hosp / Div of Clin Immuno and Allergy.

During the past decade, Montreal Gen Hosp / Div of Clin Immuno and Allergy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Allergy Therapeutics" with 1 trials sponsored, "Cytran" with 1 trials sponsored, "Dynavax Technologies Corporation" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" are "HIV Infections" (5 trials), "Rhinitis, Allergic, Seasonal" (1 trials), "Sarcoma, Kaposi" (1 trials) and "Type I Hypersensitivity" (1 trials). Many other conditions were trialed in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" in a lesser frequency.

Most popular intervention types in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (2 trials), "Stavudine" (2 trials), "Zidovudine" (2 trials), "Amb a 1 Immunostimulatory Oligoribonucleotide Conjugate" (1 trials) and "Atazanavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montreal Gen Hosp / Div of Clin Immuno and Allergy" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Montreal Gen Hosp / Div of Clin Immuno and Allergy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Montreal Gen Hosp / Div of Clin Immuno and Allergy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montreal Gen Hosp / Div of Clin Immuno and Allergy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".